QIAGEN and McGill University start Partnership for Förderung der Mikrobiomforschung

QIAGEN and McGill University Launch Joint Project in Microbiome Study, Evidence Base for Medizin and General Healthcare to Generate //McGill serves as beta test for QIAGEN’s new microbiome solutions // Partnership launches QIAGEN’s Engagement in Microbiome Research and continues Innovation at the McGill Center for Microbiome Research

Montreal, Canada, and Venlo, Netherlands, Nov. 12, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has made a proposal with the McGill University Center for Microbiome Research. Soul is that the microbiome schung is intensified and something goes wrong.

The three partnerships concerned with the development of the community of microorganisms die in one of the largest cases, one of the human microorganisms. The focus is on DNA extraction removal with small biomass microbiomass and anaerobic culture protocols.

If you note the cost of acquiring the microbiome in North America, a market with a volume of $1.8 billion is valued. The partner organization can rely on a variety of possibilities for clearing the community and its quality, the functionality of the microbial system and the possibilities of health care and the capacity of the Krankheiten are powerful. QIAGEN with the McGill Center for Microbiome Research has been investigating the analysis of a microbiological and genomic analysis of the development and merging of research projects during the demonstration, a design of QIAGEN products for the demonstration of the microbiome. The merger of the McGill Center for Microbiome Research has begun, the next generation of scientists and scientists have taken note and done the microbiology for knitting erasing machines.

“McGill University is an established institution and offers an excellent study and development program. This partnership has offered us commitment, the Mikrobiomforschung foranzutreiben,” says Nitin Sood, Senior Vice President and Leader of Geschäftsbereichs Life Sciences at QIAGEN. “These cases are very light, based on new feedback from the Microbiome and thus the community in their own country and their world, the flow of microbiomes in healthcare and the illness of their relatives.”

“Mikrobielle Gemeinschaften are a central bank for the functionality of the entire system, one of the best ways to serve people. Dennoch kratzen will now be one of the upper fläche, a verstehen, wie die reichliche vorhandenen, unglaublich veldfältigen and dynamic Gemeinschaften that bring together human health and the Ökosysteme in all by-products,” said Dr. Corinne Maurice, co-director of the McGill Center for Microbiome Research and leader of the Canadian Research Center for Microbial Interactions in the Gut. “This emerging partner with QIAGEN helps us, Mikrobiomforschern at McGill University and in the Provinz Quebec Instrumente und Methoden voor Verfügung to set, one of the Boundaries that the Wissens-stetig is to continue to exist.”

The microbiome is examined by the microorganisms that Wirt bacteria, pills, viruses and their jewelry. If you can explore one of the possibilities of the microbiomes in the field of health, disease and microbiological processes, there is a new diagnosis and therapy strategy for you.

QIAGEN products were developed in experimental platforms at the MCGill Center for Microbiome Research, which is used as a beta test set for the new Entwicklung QIAGEN products for the further development of microbiome research required. As the community is entered, QIAGENs can refine and optimize an extension of the community in the community.

The partnership is another story in QIAGEN’s strategy, microbiom research will continue. In 2024, a partnership with Penn State University in the United States was established, a joint research and development initiative for the dynamic microbiome science of establishments.

McGill University, one of the world’s top teaching universities, and the McGill Center for Microbiome Research, together with Forschern and partners, are setting up an infrastructure and resources infrastructure, an evidence-based science needed to advance Medizin and healthy healthcare improve. The Forschungszentrum can be active in the Mikrobiomforschung bundle and Synergic notes. Here is a service available that is not as simple, as there are experimental platforms, which find the Research Institute of the McGill University Health Center (Gnotobiotic Animal Research Platform) on the campus in the Innenstadt (Microbial Services Platform).

The Gnotobiotic Animal Research Platform has conducted research into microbial taxa and communities in healthcare. Speziell would be able to support those who change microbial communities to improve their health. The microbial services platform offers services for the design of experiments and is a study of the sequence presented to the culture under special anaerobic studies. Because so much has been written, there is a microbial analysis and identifying the microbes, making a mistake, which is associated with health and the associated illness.

The McGill Center for Microbiome Research has the most extensive knowledge of complex microbiological microbes and Wirten-vertiefen and microbiome research for broader scientific processes in Montreal zugänglich machen.

If you use a Microbiome Portfolio from QIAGEN, there are tools available for investigating doubtful doubts, a number of kits for a test carried out, which can be carried out for the research into the microbiomes of the most optimal human being. QIAGEN’s automated Probenvorbereitung makes the reproduction, standardization and display of Ergebnissen safe. The extended spectrum and microbiome-based solutions offer advanced technology with Next-Generation Sequencing (NGS), Digital PCR (dPCR) and Quantitative PCR (qPCR). A very extensive bioinformatics tool for a complete digital analysis is available.

More information on the solutions of QIAGEN for the microbiome research found below
https://www.qiagen.com/us/applications/microbiome.

Uber QIAGEN

QIAGEN NV, a Dutch holding company, is a prosperous company engaged in extracting molecular molecular research from biological research. QIAGEN’s research technology ensures the processing and processing of DNA, RNA and proteins from Blut, Gewebe and other substances. Testing technology can perform this biomolecular analysis and analysis. Bioinformatics solutions and financial databases help interpret dating with more relevant and practically useful research. Automation integrations integrate these cost-effective testing workflows. QIAGEN makes more than 500,000 people available with the Bereichen Molekulare Diagnostik (Gesundheitsfürsorge) and Life Sciences (akademie Forschung, pharmakologische Fund und industrial Anwendungen, hauptsächlich Forensik) for Verfügung. Zum 30. September 2024 beschäftigte QIAGEN weltweit more than 5,800 employees in über 35 Standorten. More information about QIAGEN can be found at http://www.qiagen.com.

Uber McGill University

In 1821 in Montreal, Quebec, McGill University was founded as a medical medical college. McGill would go on to rank as one of the top university institutions both nationally and internationally. It is a prosperous college with more than 39,000 years of study, 12 faculties, 14 schools and 300 years of study and more than 39,000 years of study, which employs more than 10,400 teachers. McGill sees student returns from 150 states of the world, which have 12,000 international student returns of 30% of the study results. If half of McGill students speak another first language in English, it will cost 20% with Französisch als Muttersprache.

Forward-looking statement

Einige der Angaben in dieser Pressemitteilung im Sinne von Section 27A of the US Securities Act (US-Wertpapergesetz) von 1933 in ergänzter Fassung and Section 21E of the US Securities Exchange Act (US-Börsengesetz) von 1934 in ergänzter Fassung als zkunftsgerichttete Aussagen (‘forward ‘-looking statements”). Consider the notification of market-oriented products from QIAGEN, including the responses to the COVID-19 pandemic that produces products, the Zeitplan voor marktinführungen und Entwicklungen, regulische Genehmigungen, finanzielle und operative Prognosen, Wachstum , Expansion, Collaboration, Market, Strategy or operative enterprise were not limited to that of the erwartenden Ergebnisse voor de bereinigten Nettoumsatz und de bereinigten bewässerten Gewinn je Aktie, geschieht die op de Basis der Zeitiger Erwartungen en Annahmen, die met probabile auf dem Unsavory and risk-taking . This is the case: Risks in management and international management (einschließlich Auswirkungen von Währungsschwankungen und der Abhängigkeit von regulische sowie Logistikprozessen); Schwankungen der Betriebsergebnisse und je Verteilung auf unsere Kundengruppen; the market research for our products and knowledge in academic Research, Pharma, Testing and Molecular Diagnostics; Changes in our knowledge of our capabilities, our customers and our strategic partners, our knowledge and understanding of the environment, our technological progress, our knowledge of our quality and our QIAGEN products (einschließlich overall economics, quality and efficiency of our budgets and our budgets), that Möglichkeit, die regulatory products for our product, the quality of the products of QIAGEN, an integrated product and the regenlung-solcher products, the quality of the external products, new products to integrate, and the product of the law-bewerber to use who for dem Wettbewerb zu schützen, Markttakzeptanz new products and integration of technology and technology; Maßnahmen von Regierungen; global or regional economic development; Wetter-oder transportbedingte Verzögerungen, Naturkatastrofen, Political Criticism or Criticism in the area of ​​​​Safety, a loss of Ausmaßes and the Dauer of the COVID-19 pandemic and – 3 – your Auswirkungen on the Nachfrage nach unseren Products and other Aspekte unseres s , or sonstige Ereignisse höherer Gewalt; so who has the power, as the erwartete Nutzen in the Zusammenhang with the young or anstehenden Acquisitionen, not who erwartet eintritt is; and other factors, see the “risk factors” in the annual report Form 20-F. More information can be found in messages sent by QIAGEN to the US Securities and Exchange Commission (US-Börsenaufsichtsbehörde).

Source: QIAGEN NV
Category: Business

Contact QIAGEN:

Quelle Hugin